BAGSVAERD, DENMARK--(Marketwire - December 07, 2009) - Novo Nordisk A/S - Share repurchase programme
On 7 August 2009 Novo Nordisk initiated its share repurchase
programme in accordance with the provisions of the European
Commission's regulation no 2273/2003 of 22 December 2003, also
referred to as the Safe Harbour rules.
Under the programme Novo Nordisk will repurchase B shares for an amount up to DKK 2.4 billion in the period from 10 August 2009 to 18 December 2009.
Since the announcement as of 30 November 2009, the following transactions have been made under the programme:
Number of Average Transaction value,
shares purchase price DKK
Accumulated, last
announcement 6,183,599 1,982,712,188
30 November 2009 80,000 331.9000 26,552,000
1 December 2009 84,000 336.4710 28,263,564
2 December 2009 84,000 344.3699 28,927,072
3 December 2009 90,000 337.6100 30,384,900
4 December 2009 84,000 337.0710 28,313,964
Accumulated under
the programme 6,605,599 2,125,153,688
With the transactions stated above, Novo Nordisk owns a total of
31,321,977 treasury shares, corresponding to 5.1% of the share
capital. The total amount of shares in the company is 620,000,000
including treasury shares.
Novo Nordisk is a healthcare company and a world leader in diabetes care. In addition, Novo Nordisk has a leading position within areas such as haemostasis management, growth hormone therapy and hormone replacement therapy. Novo Nordisk manufactures and markets pharmaceutical products and services that make a significant difference to patients, the medical profession and society. With headquarters in Denmark, Novo Nordisk employs more than 29,000 employees in 81 countries, and markets its products in 179 countries. Novo Nordisk's B shares are listed on the stock exchanges in Copenhagen and London. Its ADRs are listed on the New York Stock Exchange under the symbol 'NVO'. For more information, visit novonordisk.com.
Further information:
Media: Investors: Elin K Hansen Mads Veggerby Lausten Tel: (+45) 4442 3450 Tel: (+45) 4443 7919 ekh@novonordisk.com mlau@novonordisk.com Kasper Roseeuw Poulsen Tel: (+45) 4442 4471 krop@novonordisk.com In North America: In North America: Sean Clements Hans Rommer Tel: (+1) 609 514 8316 Tel: (+1) 609 919 7937 secl@novonordisk.com hrmm@novonordisk.com
Company Announcement no 72 / 2009:
http://hugin.info/2013/R/1359565/331404.pdf
This announcement was originally distributed by Hugin. The issuer is
solely responsible for the content of this announcement.
Copyright © Hugin AS 2009. All rights reserved.
